Logo image of GME.DE

GERATHERM MEDICAL AG (GME.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:GME - DE0005495626 - Common Stock

2.94 EUR
-0.01 (-0.34%)
Last: 1/16/2026, 7:00:00 PM

GME.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap15.91M
Revenue(TTM)13.98M
Net Income(TTM)705.20K
Shares5.41M
Float1.49M
52 Week High7.38
52 Week Low2.48
Yearly Dividend0.1
Dividend Yield3.39%
EPS(TTM)0.13
PE22.62
Fwd PE48.51
Earnings (Next)06-02
IPO2000-07-03
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
GME.DE short term performance overview.The bars show the price performance of GME.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

GME.DE long term performance overview.The bars show the price performance of GME.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of GME.DE is 2.94 EUR. In the past month the price decreased by -14.29%. In the past year, price decreased by -42.35%.

GERATHERM MEDICAL AG / GME Daily stock chart

GME.DE Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GME.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to GME.DE. GME.DE is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

GME.DE Financial Highlights

Over the last trailing twelve months GME.DE reported a non-GAAP Earnings per Share(EPS) of 0.13. The EPS decreased by -37.95% compared to the year before.


Industry RankSector Rank
PM (TTM) 5.04%
ROA 2.56%
ROE 3.39%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%84.62%
Sales Q2Q%-3.99%
EPS 1Y (TTM)-37.95%
Revenue 1Y (TTM)-33.29%

GME.DE Forecast & Estimates

5 analysts have analysed GME.DE and the average price target is 6.12 EUR. This implies a price increase of 108.16% is expected in the next year compared to the current price of 2.94.

For the next year, analysts expect an EPS growth of -120% and a revenue growth -12.36% for GME.DE


Analysts
Analysts80
Price Target6.12 (108.16%)
EPS Next Y-120%
Revenue Next Year-12.36%

GME.DE Ownership

Ownership
Inst Owners0.14%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

GME.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
2M6.DE MEDTRONIC PLC 17.39 107.89B
1MDT.MI MEDTRONIC PLC 17.01 105.52B
1SHL.MI SIEMENS HEALTHINEERS AG 19.62 52.88B
SHL.DE SIEMENS HEALTHINEERS AG 19.37 52.23B
PHI1.DE KONINKLIJKE PHILIPS NV 17.34 24.72B
PHIA.AS KONINKLIJKE PHILIPS NV 17.32 24.69B
BIM.PA BIOMERIEUX 27.1 12.38B
OBCK.DE OTTOBOCK SE & CO KGAA 142.55 4.29B
DIA.MI DIASORIN SPA 22.54 4.17B
AFX.DE CARL ZEISS MEDITEC AG - BR 24.5 3.53B
DRW3.DE DRAEGERWERK AG - PREF 13.62 1.65B
DRW8.DE DRAEGERWERK AG 10.7 1.29B

Related stock screener links

About GME.DE

Company Profile

GME logo image Geratherm Medical AG engages in the manufacture and distribution of medical technology products used for temperature management and medical diagnostics. The company is headquartered in Geschwenda, Thueringen and currently employs 144 full-time employees. The company went IPO on 2000-07-03. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. The Healthcare Diagnostic segment provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. The Medical Warming Systems provides solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. The Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Company Info

GERATHERM MEDICAL AG

Fahrenheitstrasse 1

Geschwenda THUERINGEN DE

Employees: 179

GME Company Website

GME Investor Relations

Phone: 4936205980

GERATHERM MEDICAL AG / GME.DE FAQ

What does GME do?

Geratherm Medical AG engages in the manufacture and distribution of medical technology products used for temperature management and medical diagnostics. The company is headquartered in Geschwenda, Thueringen and currently employs 144 full-time employees. The company went IPO on 2000-07-03. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. The Healthcare Diagnostic segment provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. The Medical Warming Systems provides solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. The Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.


Can you provide the latest stock price for GERATHERM MEDICAL AG?

The current stock price of GME.DE is 2.94 EUR. The price decreased by -0.34% in the last trading session.


Does GME stock pay dividends?

GERATHERM MEDICAL AG (GME.DE) has a dividend yield of 3.39%. The yearly dividend amount is currently 0.1.


What is the ChartMill technical and fundamental rating of GME stock?

GME.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Is GERATHERM MEDICAL AG (GME.DE) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GME.DE.


Can you provide the number of employees for GERATHERM MEDICAL AG?

GERATHERM MEDICAL AG (GME.DE) currently has 179 employees.